Actively Recruiting
CBT Effects on Neural, Physiological, and Attentional Responses in Anorexia Nervosa
Led by Istanbul Nisantasi University · Updated on 2025-06-25
60
Participants Needed
1
Research Sites
21 weeks
Total Duration
On this page
Sponsors
I
Istanbul Nisantasi University
Lead Sponsor
U
Uskudar University
Collaborating Sponsor
AI-Summary
What this Trial Is About
This randomized controlled trial investigates the neurophysiological, physiological, and attentional effects of Cognitive-Behavioral Therapy (CBT) in individuals with restrictive-type anorexia nervosa (AN). The study compares two groups: one receiving a 12-week CBT intervention, and one placed on a waitlist (no active treatment during the study period). All participants undergo pre- and post-intervention assessments using electroencephalography (EEG), galvanic skin response (GSR), and eye-tracking while exposed to visual stimuli related to food, body image, and self-appearance. The primary outcomes include neural changes in attention and emotional processing (P300, LPP, frontal alpha asymmetry), physiological arousal (skin conductance), and visual attention biases (fixation duration and gaze distribution). The aim is to determine whether CBT leads to measurable improvements in neurobiological and attentional mechanisms related to body image disturbance and food-related anxiety in AN, contributing to biomarker-informed psychotherapy approaches.
CONDITIONS
Official Title
CBT Effects on Neural, Physiological, and Attentional Responses in Anorexia Nervosa
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female participants aged 18 to 35
- Diagnosed with restrictive-type anorexia nervosa according to DSM-5
- Body Mass Index (BMI) between 15.0 and 18.5
- Medically stable to participate in psychological and neurophysiological assessments
- Willing to attend weekly therapy sessions (for the CBT group) and complete pre- and post-assessments
- Able to provide informed consent
You will not qualify if you...
- Current or past diagnosis of bulimia nervosa, binge-eating disorder, or other eating disorders
- Severe psychiatric disorders such as psychosis, bipolar disorder, or substance use disorder
- History of neurological illness or traumatic brain injury
- Use of psychotropic medication within the last 6 weeks
- Previous participation in structured Cognitive-Behavioral Therapy for an eating disorder
- Pregnancy
- Visual or neurological impairments preventing accurate EEG, GSR, or eye-tracking recordings
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Üsküdar University Neuro Marketing Lab.
Istanbul, Turkey (Türkiye)
Actively Recruiting
Research Team
M
Metin Çınaroğlu, Phd
CONTACT
S
Selami Varol Ülker, Phd
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here